Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 126 for novartis
Company Exchange Symbol Last price Quote change Market cap
Novartis AG (ADR) NYSE NVS 79.94 -0.36 (-0.45%) 210.15B
Novartis AG is a holding company. The Company specializes in the research, development, manufacturing and marketing of a range of healthcare products led by ...
Novartis AG VTX NOVN 77.35 -1.10 (-1.40%) 203.82B
Novartis AG is a holding company. The Company specializes in the research, development, manufacturing and marketing of a range of healthcare products led by ...
NOVARTIS AG CHF0.50 (REGD) OTCMKTS NVSEF 79.89 -0.06 (-0.07%) 210.04B
Novartis India Limited BOM 500672 711.95 +0.75 (0.11%) 22.80B
Novartis India Limited is engaged in the manufacture of drugs, medicines and allied products. The Company's segments include Pharmaceuticals, Generics, ...
NOVARTIS PHARMACEUTICALS CORPORATION Private
As the US pharmaceuticals unit of Swiss drug giant Novartis AG, Novartis Pharmaceuticals Corporation (NPC) helps with the development, manufacturing, ...
NOVARTIS NAM. SF 0,50 ETR NOT 70.88 -1.13 (-1.57%)
NOVARTIS NAM. ADR 1 FRA NOTA 71.06 -0.69 (-0.96%)
NOVARTIS NAM. SF 0,50 FRA NOT 70.88 -1.01 (-1.41%)
NOVARTIS NAM. ADR 1 ETR NOTA 70.56 -1.54 (-2.14%)
Novartis Corporation Private
Novartis Corporation has what the doctor ordered. As the US headquarters of Switzerland-based Novartis AG, the unit handles administration, sales, ...
NOVARTIS UK LIMITED Private
True to its name, Novartis UK is the UK arm of Swiss-based Novartis AG. From nine locations across the UK, it conducts research and development, ...
NOVARTIS N 2. LINIE SWX NOVNEE 77.43 -1.00 (-1.28%)
NOVARTIS AG CEDEAR EACH REP 0.5 ADR BCBA NVS 605.50 0.00 (0.00%)
MorphoSys AG ETR MOR 38.65 -0.88 (-2.23%) 1.03B
MorphoSys AG (MorphoSys) develops and commercializes antibodies for therapeutic applications. The Company's operating segments include Proprietary ...
Celgene Corporation NASDAQ CELG 110.21 -0.39 (-0.35%) 82.87B
Celgene Corporation (Celgene) is a biopharmaceutical company. The Company together with its subsidiaries is engaged primarily in the discovery, ...
Morphosys Ag (ADR) OTCMKTS MPSYY 21.89 0.00 (0.00%) 1.16B
MorphoSys AG (MorphoSys) develops and commercializes antibodies for therapeutic applications. The Company's operating segments include Proprietary ...
MorphoSys AG FRA MOR 38.30 -1.01 (-2.56%) 1.02B
MorphoSys AG (MorphoSys) develops and commercializes antibodies for therapeutic applications. The Company's operating segments include Proprietary ...
Morphosys SWX MOR 41.89 0.00 (0.00%)
ImmunoGen, Inc. NASDAQ IMGN 2.99 +0.02 (0.67%) 246.26M
The Company's partners are Amgen Inc., Bayer HealthCare (a subgroup of Bayer AG) , Biotest AG, Eli Lilly and Company (Lilly), Novartis Institutes for ...
SPDR S&P Emerging Middle Est & Afrca ETF NYSEARCA GAF 60.49 0.00 (0.00%) 28.20M
SPDR S&P Emerging Middle East & Africa ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI Middle ...